GLP1R and type 2 diabetes mellitus: Some drugs approved for treatment of type 2 diabetes have been investigated in pediatric T1D, such as thiazolidinediones (24) and glucagon-like peptide 1 receptor agonists (25), and a growing number of immunotherapy studies (26–31) are being conducted.